speb/financial-data huggingface dataset:
ADME.L income_statement (annual, 2021-12-31) — Tax Provision: 0.00
ADME.L income_statement (annual, 2021-12-31) — Tax Rate For Calcs: 0.00
ADME.L balance_sheet (annual, 2021-12-31) — Total Assets: 17026000.00
ADME.L balance_sheet (annual, 2021-12-31) — Total Capitalization: 11233000.00
ADME.L balance_sheet (annual, 2021-12-31) — Total Debt: 459000.00
ADME.L balance_sheet (annual, 2021-12-31) — Total Equity Gross Minority Interest: 10986000.00
ADME.L income_statement (annual, 2021-12-31) — Total Expenses: 4235000.00
ADME.L balance_sheet (annual, 2021-12-31) — Total Liabilities Net Minority Interest: 6040000.00
ADME.L balance_sheet (annual, 2021-12-31) — Total Non Current Assets: 16725000.00
ADME.L balance_sheet (annual, 2021-12-31) — Total Non Current Liabilities Net Minority Interest: 4294000.00
ADME.L income_statement (annual, 2021-12-31) — Total Operating Income As Reported: -2484000.00
ADME.L balance_sheet (annual, 2021-12-31) — Total Tax Payable: 592000.00
ADME.L income_statement (annual, 2021-12-31) — Total Unusual Items: 0.00
ADME.L income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: 0.00
ADME.L balance_sheet (annual, 2021-12-31) — Tradeand Other Payables Non Current: 2783000.00
ADME.L balance_sheet (annual, 2021-12-31) — Working Capital: -1445000.00
ADME.L income_statement (annual, 2021-12-31) — Write Off: 0.00
ADME.L income_statement (annual, 2022-12-31) — +Operating Expense: 2092000.00
ADME.L income_statement (annual, 2022-12-31) — +Total Revenue: 662000.00
ADME.L balance_sheet (annual, 2022-12-31) — Accounts Payable: 2240000.00
ADME.L balance_sheet (annual, 2022-12-31) — Accounts Receivable: 22000.00
ADME.L balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -5820000.00
ADME.L balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 38090000.00
ADME.L income_statement (annual, 2022-12-31) — Basic Average Shares: 252369021.00
ADME.L income_statement (annual, 2022-12-31) — Basic EPS: -0.01
ADME.L cash_flow (annual, 2022-12-31) — Beginning Cash Position: 110000.00
ADME.L balance_sheet (annual, 2022-12-31) — Capital Stock: 2972000.00
ADME.L balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 25000.00
ADME.L balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 53000.00
ADME.L balance_sheet (annual, 2022-12-31) — Cash Financial: 25000.00
ADME.L cash_flow (annual, 2022-12-31) — Change In Inventory: 0.00
ADME.L cash_flow (annual, 2022-12-31) — Change In Payable: 138000.00
ADME.L cash_flow (annual, 2022-12-31) — Change In Receivables: 108000.00
ADME.L cash_flow (annual, 2022-12-31) — Change In Working Capital: 246000.00
ADME.L cash_flow (annual, 2022-12-31) — Changes In Cash: -94000.00
ADME.L balance_sheet (annual, 2022-12-31) — Common Stock: 2972000.00
ADME.L balance_sheet (annual, 2022-12-31) — Common Stock Equity: 7138000.00
ADME.L cash_flow (annual, 2022-12-31) — Common Stock Issuance: 1061000.00
ADME.L balance_sheet (annual, 2022-12-31) — Current Assets: 111000.00
ADME.L balance_sheet (annual, 2022-12-31) — Current Debt: 0.00
ADME.L balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 0.00
ADME.L balance_sheet (annual, 2022-12-31) — Current Liabilities: 2240000.00
ADME.L cash_flow (annual, 2022-12-31) — Depreciation: 65000.00
ADME.L cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 0.00
ADME.L income_statement (annual, 2022-12-31) — Diluted Average Shares: 252369021.00
ADME.L income_statement (annual, 2022-12-31) — Diluted EPS: -0.01
ADME.L income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -2122000.00
ADME.L income_statement (annual, 2022-12-31) — EBIT: -2006000.00
ADME.L income_statement (annual, 2022-12-31) — EBITDA: -2006000.00
ADME.L cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 9000.00
ADME.L cash_flow (annual, 2022-12-31) — End Cash Position: 25000.00
ADME.L cash_flow (annual, 2022-12-31) — Financing Cash Flow: 887000.00
ADME.L cash_flow (annual, 2022-12-31) — Free Cash Flow: -981000.00
ADME.L cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
ADME.L income_statement (annual, 2022-12-31) — General And Administrative Expense: 1723000.00
ADME.L balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 17899000.00
ADME.L balance_sheet (annual, 2022-12-31) — Gross PPE: 23719000.00
ADME.L income_statement (annual, 2022-12-31) — Interest Expense: 116000.00
ADME.L income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 116000.00
ADME.L balance_sheet (annual, 2022-12-31) — Inventory: 36000.00
ADME.L balance_sheet (annual, 2022-12-31) — Invested Capital: 7425000.00
ADME.L cash_flow (annual, 2022-12-31) — Investing Cash Flow: 0.00
ADME.L balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 0.00
ADME.L balance_sheet (annual, 2022-12-31) — Investmentsin Subsidiariesat Cost: 0.00
ADME.L cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 1061000.00
ADME.L cash_flow (annual, 2022-12-31) — Issuance Of Debt: 210000.00
ADME.L balance_sheet (annual, 2022-12-31) — Long Term Debt: 287000.00
ADME.L balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 287000.00
ADME.L cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 210000.00
ADME.L cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -328000.00
ADME.L balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 0.00
ADME.L balance_sheet (annual, 2022-12-31) — Long Term Provisions: 5627000.00
ADME.L cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
ADME.L cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 1061000.00
ADME.L balance_sheet (annual, 2022-12-31) — Net Debt: 262000.00
ADME.L cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
ADME.L income_statement (annual, 2022-12-31) — Net Income: -2122000.00
ADME.L income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -2122000.00
ADME.L income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -2122000.00
ADME.L income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -2122000.00
ADME.L income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -2122000.00
ADME.L cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -2122000.00
ADME.L income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -2122000.00
ADME.L income_statement (annual, 2022-12-31) — Net Interest Income: -116000.00
ADME.L cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 0.00
ADME.L cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -118000.00
ADME.L cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -118000.00
ADME.L income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -116000.00
ADME.L balance_sheet (annual, 2022-12-31) — Net PPE: 17899000.00
ADME.L cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
ADME.L balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 7138000.00
ADME.L income_statement (annual, 2022-12-31) — Normalized EBITDA: -1430000.00
ADME.L income_statement (annual, 2022-12-31) — Normalized Income: -1546000.00
ADME.L cash_flow (annual, 2022-12-31) — Operating Cash Flow: -981000.00
ADME.L income_statement (annual, 2022-12-31) — Operating Income: -1430000.00
ADME.L income_statement (annual, 2022-12-31) — Operating Revenue: 662000.00
ADME.L balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 297147530.00
ADME.L balance_sheet (annual, 2022-12-31) — Other Equity Interest: 9184000.00
ADME.L balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 17899000.00
ADME.L cash_flow (annual, 2022-12-31) — Other Non Cash Items: 254000.00
ADME.L income_statement (annual, 2022-12-31) — Other Operating Expenses: 369000.00
ADME.L balance_sheet (annual, 2022-12-31) — Other Payable: 38000.00
ADME.L balance_sheet (annual, 2022-12-31) — Other Receivables: 22000.00
ADME.L balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 28000.00
ADME.L income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
ADME.L balance_sheet (annual, 2022-12-31) — Payables: 2240000.00
ADME.L income_statement (annual, 2022-12-31) — Pretax Income: -2122000.00
ADME.L balance_sheet (annual, 2022-12-31) — Properties: 23719000.00
ADME.L cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
ADME.L income_statement (annual, 2022-12-31) — Reconciled Depreciation: 0.00
ADME.L cash_flow (annual, 2022-12-31) — Repayment Of Debt: -328000.00
ADME.L balance_sheet (annual, 2022-12-31) — Retained Earnings: -43738000.00
ADME.L cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
ADME.L income_statement (annual, 2022-12-31) — Selling General And Administration: 1723000.00
ADME.L balance_sheet (annual, 2022-12-31) — Share Issued: 297147530.00
ADME.L cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
ADME.L income_statement (annual, 2022-12-31) — Special Income Charges: -576000.00
ADME.L cash_flow (annual, 2022-12-31) — Stock Based Compensation: 0.00
ADME.L balance_sheet (annual, 2022-12-31) — Stockholders Equity: 7138000.00
ADME.L balance_sheet (annual, 2022-12-31) — Tangible Book Value: 7138000.00
ADME.L income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
ADME.L income_statement (annual, 2022-12-31) — Tax Provision: 0.00
ADME.L income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
ADME.L balance_sheet (annual, 2022-12-31) — Total Assets: 18010000.00
ADME.L balance_sheet (annual, 2022-12-31) — Total Capitalization: 7425000.00
ADME.L balance_sheet (annual, 2022-12-31) — Total Debt: 287000.00
ADME.L balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 7138000.00
ADME.L income_statement (annual, 2022-12-31) — Total Expenses: 2092000.00
ADME.L balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 10872000.00
ADME.L balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 17899000.00
ADME.L balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 8632000.00
ADME.L income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -2006000.00
ADME.L balance_sheet (annual, 2022-12-31) — Total Tax Payable: 414000.00
ADME.L income_statement (annual, 2022-12-31) — Total Unusual Items: -576000.00
ADME.L income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -576000.00
ADME.L balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 2718000.00
ADME.L balance_sheet (annual, 2022-12-31) — Working Capital: -2129000.00
ADME.L income_statement (annual, 2022-12-31) — Write Off: 576000.00
ADME.L income_statement (annual, 2023-12-31) — +Operating Expense: 1617000.00
ADME.L income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
ADME.L balance_sheet (annual, 2023-12-31) — Accounts Payable: 668000.00
ADME.L balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -22400000.00
ADME.L balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 38236000.00
ADME.L income_statement (annual, 2023-12-31) — Basic Average Shares: 352852268.00
ADME.L income_statement (annual, 2023-12-31) — Basic EPS: -0.05
ADME.L cash_flow (annual, 2023-12-31) — Beginning Cash Position: 25000.00
ADME.L balance_sheet (annual, 2023-12-31) — Capital Stock: 4850000.00
ADME.L balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 0.00
ADME.L balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 0.00
ADME.L balance_sheet (annual, 2023-12-31) — Cash Financial: 0.00
ADME.L cash_flow (annual, 2023-12-31) — Change In Inventory: 36000.00
ADME.L cash_flow (annual, 2023-12-31) — Change In Payable: 153000.00
ADME.L cash_flow (annual, 2023-12-31) — Change In Receivables: 0.00
ADME.L cash_flow (annual, 2023-12-31) — Change In Working Capital: 189000.00
ADME.L cash_flow (annual, 2023-12-31) — Changes In Cash: 39000.00
ADME.L balance_sheet (annual, 2023-12-31) — Common Stock: 4850000.00
ADME.L balance_sheet (annual, 2023-12-31) — Common Stock Equity: -8924000.00
ADME.L cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
ADME.L income_statement (annual, 2023-12-31) — Cost Of Revenue: 0.00
ADME.L balance_sheet (annual, 2023-12-31) — Current Assets: 18000.00
ADME.L balance_sheet (annual, 2023-12-31) — Current Debt: 950000.00
ADME.L balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 950000.00
ADME.L balance_sheet (annual, 2023-12-31) — Current Liabilities: 2963000.00
ADME.L cash_flow (annual, 2023-12-31) — Depreciation: 57000.00
ADME.L cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 57000.00
ADME.L income_statement (annual, 2023-12-31) — Diluted Average Shares: 352852268.00
ADME.L income_statement (annual, 2023-12-31) — Diluted EPS: -0.05
ADME.L income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -17578000.00
ADME.L income_statement (annual, 2023-12-31) — EBIT: -17315000.00
ADME.L income_statement (annual, 2023-12-31) — EBITDA: -17258000.00
ADME.L cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -64000.00
ADME.L cash_flow (annual, 2023-12-31) — End Cash Position: 0.00
ADME.L cash_flow (annual, 2023-12-31) — Financing Cash Flow: 773000.00
ADME.L cash_flow (annual, 2023-12-31) — Free Cash Flow: -726000.00
ADME.L cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: -1456000.00
ADME.L cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 501000.00
ADME.L income_statement (annual, 2023-12-31) — General And Administrative Expense: 1595000.00
ADME.L balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 357000.00
ADME.L balance_sheet (annual, 2023-12-31) — Gross PPE: 23241000.00
ADME.L income_statement (annual, 2023-12-31) — Gross Profit: 0.00
ADME.L income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 16843000.00
ADME.L income_statement (annual, 2023-12-31) — Interest Expense: 263000.00
ADME.L income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 263000.00
ADME.L income_statement (annual, 2023-12-31) — Interest Income: 0.00
ADME.L income_statement (annual, 2023-12-31) — Interest Income Non Operating: 0.00
ADME.L balance_sheet (annual, 2023-12-31) — Inventory: 0.00
ADME.L balance_sheet (annual, 2023-12-31) — Invested Capital: -7315000.00
ADME.L cash_flow (annual, 2023-12-31) — Investing Cash Flow: -8000.00
ADME.L balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 1085000.00
ADME.L balance_sheet (annual, 2023-12-31) — Investmentsin Subsidiariesat Cost: 0.00
ADME.L cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
ADME.L cash_flow (annual, 2023-12-31) — Issuance Of Debt: 793000.00
ADME.L balance_sheet (annual, 2023-12-31) — Long Term Debt: 659000.00
ADME.L balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 659000.00
ADME.L cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 343000.00
ADME.L cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -20000.00
ADME.L balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 1085000.00
ADME.L balance_sheet (annual, 2023-12-31) — Long Term Provisions: 5943000.00
ADME.L cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -8000.00
ADME.L cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
ADME.L balance_sheet (annual, 2023-12-31) — Net Debt: 1609000.00
ADME.L cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 420000.00
ADME.L income_statement (annual, 2023-12-31) — Net Income: -17578000.00
ADME.L income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -17578000.00
ADME.L income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -17578000.00
ADME.L income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -17578000.00
ADME.L income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -17578000.00
ADME.L cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -17578000.00
ADME.L income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -17578000.00
ADME.L income_statement (annual, 2023-12-31) — Net Interest Income: -263000.00
ADME.L cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 773000.00
ADME.L cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 323000.00
ADME.L income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -263000.00
ADME.L balance_sheet (annual, 2023-12-31) — Net PPE: 841000.00
ADME.L cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 450000.00
ADME.L balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -8924000.00
ADME.L income_statement (annual, 2023-12-31) — Normalized EBITDA: -1560000.00
ADME.L income_statement (annual, 2023-12-31) — Normalized Income: -1880000.00
ADME.L cash_flow (annual, 2023-12-31) — Operating Cash Flow: -726000.00
ADME.L income_statement (annual, 2023-12-31) — Operating Income: -1617000.00
ADME.L income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
ADME.L balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 484938611.00
ADME.L balance_sheet (annual, 2023-12-31) — Other Equity Interest: 9227000.00
ADME.L balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 357000.00
ADME.L cash_flow (annual, 2023-12-31) — Other Non Cash Items: -1259000.00
ADME.L income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 1521000.00
ADME.L income_statement (annual, 2023-12-31) — Other Operating Expenses: 22000.00
ADME.L balance_sheet (annual, 2023-12-31) — Other Payable: 524000.00
ADME.L balance_sheet (annual, 2023-12-31) — Other Receivables: 18000.00
ADME.L income_statement (annual, 2023-12-31) — Other Special Charges: -1145000.00
ADME.L income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
ADME.L balance_sheet (annual, 2023-12-31) — Payables: 1419000.00
ADME.L income_statement (annual, 2023-12-31) — Pretax Income: -17578000.00
ADME.L balance_sheet (annual, 2023-12-31) — Properties: 23241000.00
ADME.L cash_flow (annual, 2023-12-31) — Purchase Of Business: -8000.00
ADME.L income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 0.00
ADME.L income_statement (annual, 2023-12-31) — Reconciled Depreciation: 57000.00
ADME.L cash_flow (annual, 2023-12-31) — Repayment Of Debt: -20000.00
ADME.L income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 0.00
ADME.L balance_sheet (annual, 2023-12-31) — Retained Earnings: -61316000.00
ADME.L income_statement (annual, 2023-12-31) — Selling General And Administration: 1595000.00
ADME.L balance_sheet (annual, 2023-12-31) — Share Issued: 484938611.00
ADME.L cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 450000.00
ADME.L income_statement (annual, 2023-12-31) — Special Income Charges: -15698000.00
ADME.L cash_flow (annual, 2023-12-31) — Stock Based Compensation: 18000.00
ADME.L balance_sheet (annual, 2023-12-31) — Stockholders Equity: -8924000.00
ADME.L balance_sheet (annual, 2023-12-31) — Tangible Book Value: -8924000.00
ADME.L income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
ADME.L income_statement (annual, 2023-12-31) — Tax Provision: 0.00
ADME.L income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
ADME.L balance_sheet (annual, 2023-12-31) — Total Assets: 1944000.00
ADME.L balance_sheet (annual, 2023-12-31) — Total Capitalization: -8265000.00
ADME.L balance_sheet (annual, 2023-12-31) — Total Debt: 1609000.00
ADME.L balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -8924000.00
ADME.L income_statement (annual, 2023-12-31) — Total Expenses: 1617000.00
ADME.L balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 10868000.00
ADME.L balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1926000.00
ADME.L balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 7905000.00
ADME.L income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -17315000.00
ADME.L balance_sheet (annual, 2023-12-31) — Total Tax Payable: 227000.00
ADME.L income_statement (annual, 2023-12-31) — Total Unusual Items: -15698000.00
ADME.L income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -15698000.00
ADME.L balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 1303000.00
ADME.L balance_sheet (annual, 2023-12-31) — Working Capital: -2945000.00
ADME.L income_statement (annual, 2023-12-31) — Write Off: 0.00
ADME.L income_statement (annual, 2024-12-31) — +Operating Expense: -1689000.00
ADME.L income_statement (annual, 2024-12-31) — +Total Revenue: 95000.00
ADME.L balance_sheet (annual, 2024-12-31) — Accounts Payable: 968000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 968000.00
ADME.L balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -22908000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -22908000.00
ADME.L balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 38236000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 38236000.00
ADME.L income_statement (annual, 2024-12-31) — Basic Average Shares: 575936460.00
ADME.L income_statement (annual, 2024-12-31) — Basic EPS: 0.00
ADME.L cash_flow (annual, 2024-12-31) — Beginning Cash Position: 0.00
ADME.L balance_sheet (annual, 2024-12-31) — Capital Stock: 6279000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Capital Stock: 6279000.00
ADME.L balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 0.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 0.00
ADME.L balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 0.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 0.00
ADME.L balance_sheet (annual, 2024-12-31) — Cash Financial: 0.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Cash Financial: 0.00
ADME.L cash_flow (annual, 2024-12-31) — Change In Inventory: 0.00
ADME.L cash_flow (annual, 2024-12-31) — Change In Payable: -236000.00
ADME.L cash_flow (annual, 2024-12-31) — Change In Receivables: -36000.00
ADME.L cash_flow (annual, 2024-12-31) — Change In Working Capital: -272000.00
ADME.L cash_flow (annual, 2024-12-31) — Changes In Cash: 0.00
ADME.L balance_sheet (annual, 2024-12-31) — Common Stock: 6279000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Common Stock: 6279000.00
ADME.L balance_sheet (annual, 2024-12-31) — Common Stock Equity: -7263000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: -7263000.00
ADME.L cash_flow (annual, 2024-12-31) — Common Stock Issuance: 77000.00
ADME.L income_statement (annual, 2024-12-31) — Cost Of Revenue: 38000.00
ADME.L balance_sheet (annual, 2024-12-31) — Current Assets: 291000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Current Assets: 291000.00
ADME.L balance_sheet (annual, 2024-12-31) — Current Debt: 2005000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Current Debt: 2005000.00
ADME.L balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 2005000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 2005000.00
ADME.L balance_sheet (annual, 2024-12-31) — Current Liabilities: 3644000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 3644000.00
ADME.L cash_flow (annual, 2024-12-31) — Depreciation: 39000.00
ADME.L cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 39000.00
ADME.L income_statement (annual, 2024-12-31) — Diluted Average Shares: 584012642.00
ADME.L income_statement (annual, 2024-12-31) — Diluted EPS: 0.00
ADME.L income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 53000.00
ADME.L income_statement (annual, 2024-12-31) — EBIT: 607000.00
ADME.L income_statement (annual, 2024-12-31) — EBITDA: 646000.00
ADME.L cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 0.00
ADME.L cash_flow (annual, 2024-12-31) — End Cash Position: 0.00
ADME.L cash_flow (annual, 2024-12-31) — Financing Cash Flow: 858000.00
ADME.L cash_flow (annual, 2024-12-31) — Free Cash Flow: -700000.00
ADME.L cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
ADME.L income_statement (annual, 2024-12-31) — General And Administrative Expense: 836000.00
ADME.L balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
ADME.L balance_sheet (annual, 2024-12-31) — Gross PPE: 24181000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Gross PPE: 24181000.00
ADME.L income_statement (annual, 2024-12-31) — Gross Profit: 57000.00
ADME.L income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 438000.00
ADME.L income_statement (annual, 2024-12-31) — Interest Expense: 554000.00
ADME.L income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 554000.00
ADME.L income_statement (annual, 2024-12-31) — Interest Income: 12000.00
ADME.L income_statement (annual, 2024-12-31) — Interest Income Non Operating: 12000.00
ADME.L balance_sheet (annual, 2024-12-31) — Inventory: 0.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Inventory: 0.00
ADME.L balance_sheet (annual, 2024-12-31) — Invested Capital: -4419000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Invested Capital: -4419000.00
ADME.L cash_flow (annual, 2024-12-31) — Investing Cash Flow: -158000.00
ADME.L balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 532000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Investmentsin Associatesat Cost: 532000.00
ADME.L balance_sheet (annual, 2024-12-31) — Investmentsin Subsidiariesat Cost: 0.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Investmentsin Subsidiariesat Cost: 0.00
ADME.L cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 77000.00
ADME.L cash_flow (annual, 2024-12-31) — Issuance Of Debt: 873000.00
ADME.L balance_sheet (annual, 2024-12-31) — Long Term Debt: 839000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 839000.00
ADME.L balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 839000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 839000.00
ADME.L cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 678000.00
ADME.L cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -92000.00
ADME.L balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 532000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 532000.00
ADME.L balance_sheet (annual, 2024-12-31) — Long Term Provisions: 3394000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Long Term Provisions: 3394000.00
ADME.L balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: -38000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: -38000.00
ADME.L cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
ADME.L cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 77000.00
ADME.L balance_sheet (annual, 2024-12-31) — Net Debt: 2844000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Net Debt: 2844000.00
ADME.L cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -209000.00
ADME.L income_statement (annual, 2024-12-31) — Net Income: 53000.00
ADME.L income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 53000.00
ADME.L income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 53000.00
ADME.L income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 53000.00
ADME.L income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 53000.00
ADME.L cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 53000.00
ADME.L income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 53000.00
ADME.L income_statement (annual, 2024-12-31) — Net Interest Income: -542000.00
ADME.L cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 781000.00
ADME.L cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 586000.00
ADME.L income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -542000.00
ADME.L balance_sheet (annual, 2024-12-31) — Net PPE: 1273000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Net PPE: 1273000.00
ADME.L cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 195000.00
ADME.L balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -7263000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -7263000.00
ADME.L income_statement (annual, 2024-12-31) — Normalized EBITDA: 1388000.00
ADME.L income_statement (annual, 2024-12-31) — Normalized Income: 795000.00
ADME.L cash_flow (annual, 2024-12-31) — Operating Cash Flow: -700000.00
ADME.L income_statement (annual, 2024-12-31) — Operating Income: 1746000.00
ADME.L income_statement (annual, 2024-12-31) — Operating Revenue: 95000.00
ADME.L balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 627863811.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 627863811.00
ADME.L balance_sheet (annual, 2024-12-31) — Other Equity Interest: 9238000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 9238000.00
ADME.L cash_flow (annual, 2024-12-31) — Other Non Cash Items: -2055000.00
ADME.L income_statement (annual, 2024-12-31) — Other Operating Expenses: -2501000.00
ADME.L balance_sheet (annual, 2024-12-31) — Other Payable: 21000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Other Payable: 21000.00
ADME.L balance_sheet (annual, 2024-12-31) — Other Receivables: 291000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Other Receivables: 291000.00
ADME.L income_statement (annual, 2024-12-31) — Other Special Charges: -125000.00
ADME.L income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
ADME.L balance_sheet (annual, 2024-12-31) — Payables: 1189000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Payables: 1189000.00
ADME.L income_statement (annual, 2024-12-31) — Pretax Income: 53000.00
ADME.L balance_sheet (annual, 2024-12-31) — Properties: 24219000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Properties: 24219000.00
ADME.L cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
ADME.L income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 38000.00
ADME.L income_statement (annual, 2024-12-31) — Reconciled Depreciation: 39000.00
ADME.L cash_flow (annual, 2024-12-31) — Repayment Of Debt: -92000.00
ADME.L income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: -495000.00
ADME.L balance_sheet (annual, 2024-12-31) — Retained Earnings: -61247000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -61247000.00
ADME.L income_statement (annual, 2024-12-31) — Selling General And Administration: 836000.00
ADME.L balance_sheet (annual, 2024-12-31) — Share Issued: 627863811.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Share Issued: 627863811.00
ADME.L cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 195000.00
ADME.L income_statement (annual, 2024-12-31) — Special Income Charges: -742000.00
ADME.L cash_flow (annual, 2024-12-31) — Stock Based Compensation: 22000.00
ADME.L balance_sheet (annual, 2024-12-31) — Stockholders Equity: -7263000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: -7263000.00
ADME.L balance_sheet (annual, 2024-12-31) — Tangible Book Value: -7263000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -7263000.00
ADME.L income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ADME.L income_statement (annual, 2024-12-31) — Tax Provision: 0.00
ADME.L income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
ADME.L balance_sheet (annual, 2024-12-31) — Total Assets: 2096000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Total Assets: 2096000.00
ADME.L balance_sheet (annual, 2024-12-31) — Total Capitalization: -6424000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Total Capitalization: -6424000.00
ADME.L balance_sheet (annual, 2024-12-31) — Total Debt: 2844000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Total Debt: 2844000.00
ADME.L balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -7263000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: -7263000.00
ADME.L income_statement (annual, 2024-12-31) — Total Expenses: -1651000.00
ADME.L balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 9359000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 9359000.00
ADME.L balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1805000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 1805000.00
ADME.L balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 5715000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 5715000.00
ADME.L income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 1004000.00
ADME.L balance_sheet (annual, 2024-12-31) — Total Tax Payable: 200000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 200000.00
ADME.L income_statement (annual, 2024-12-31) — Total Unusual Items: -742000.00
ADME.L income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -742000.00
ADME.L balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 1482000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 1482000.00
ADME.L balance_sheet (annual, 2024-12-31) — Working Capital: -3353000.00
ADME.L balance_sheet (quarterly, 2024-12-31) — Working Capital: -3353000.00
ADME.L income_statement (annual, 2024-12-31) — Write Off: 924000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 2216000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 334000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 38197000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Capital Stock: 15600000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Common Stock: 15600000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -7309000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Current Assets: 335000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Current Debt: 1279000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1279000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 3495000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 519000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Gross PPE: 659000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Invested Capital: -6030000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Investmentsin Associatesat Cost: 397000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 0.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 0.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 397000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 3403000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Net Debt: 1278000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Net PPE: 659000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -7828000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1726874644.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Other Properties: 659000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Payables: 2216000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -62445000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Share Issued: 1726874644.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -7309000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -7828000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Total Assets: 1910000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -7309000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Total Debt: 1279000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -7309000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 9219000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1575000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 5724000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 2321000.00
ADME.L balance_sheet (quarterly, 2025-06-30) — Working Capital: -3160000.00
ADN.AX income_statement (annual, 2021-06-30) — +Operating Expense: 6327887.00
ADN.AX balance_sheet (annual, 2021-06-30) — Accounts Payable: 1110176.00
ADN.AX balance_sheet (annual, 2021-06-30) — Accumulated Depreciation: -329117.00
ADN.AX income_statement (annual, 2021-06-30) — Basic Average Shares: 1967778546.00
ADN.AX income_statement (annual, 2021-06-30) — Basic EPS: 0.00
ADN.AX cash_flow (annual, 2021-06-30) — Beginning Cash Position: 2998626.00
ADN.AX cash_flow (annual, 2021-06-30) — Capital Expenditure: -5122775.00
ADN.AX cash_flow (annual, 2021-06-30) — Capital Expenditure Reported: -5010162.00
ADN.AX balance_sheet (annual, 2021-06-30) — Capital Lease Obligations: 83565.00
ADN.AX balance_sheet (annual, 2021-06-30) — Capital Stock: 56929522.00
ADN.AX balance_sheet (annual, 2021-06-30) — Cash And Cash Equivalents: 4904719.00
ADN.AX balance_sheet (annual, 2021-06-30) — Cash Cash Equivalents And Short Term Investments: 4904719.00
ADN.AX balance_sheet (annual, 2021-06-30) — Cash Financial: 4904719.00
ADN.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Financing Activities: 7923679.00
ADN.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Investing Activities: -4280046.00
ADN.AX cash_flow (annual, 2021-06-30) — Cash Flowsfromusedin Operating Activities Direct: -1737540.00
ADN.AX cash_flow (annual, 2021-06-30) — Changes In Cash: 1906093.00
ADN.AX cash_flow (annual, 2021-06-30) — Classesof Cash Payments: -1799540.00
ADN.AX cash_flow (annual, 2021-06-30) — Classesof Cash Receiptsfrom Operating Activities: 62000.00
ADN.AX balance_sheet (annual, 2021-06-30) — Common Stock: 56929522.00
ADN.AX balance_sheet (annual, 2021-06-30) — Common Stock Equity: 16489210.00
ADN.AX cash_flow (annual, 2021-06-30) — Common Stock Issuance: 8021735.00
ADN.AX cash_flow (annual, 2021-06-30) — Common Stock Payments: -25056.00
ADN.AX balance_sheet (annual, 2021-06-30) — Construction In Progress: 38288.00
ADN.AX balance_sheet (annual, 2021-06-30) — Current Assets: 5758646.00
ADN.AX balance_sheet (annual, 2021-06-30) — Current Capital Lease Obligation: 56974.00
ADN.AX balance_sheet (annual, 2021-06-30) — Current Debt And Capital Lease Obligation: 56974.00
ADN.AX balance_sheet (annual, 2021-06-30) — Current Liabilities: 1209083.00
ADN.AX income_statement (annual, 2021-06-30) — Depreciation Amortization Depletion Income Statement: 93227.00
ADN.AX income_statement (annual, 2021-06-30) — Depreciation And Amortization In Income Statement: 93227.00
ADN.AX income_statement (annual, 2021-06-30) — Depreciation Income Statement: 93227.00
ADN.AX income_statement (annual, 2021-06-30) — Diluted Average Shares: 1967778546.00
ADN.AX income_statement (annual, 2021-06-30) — Diluted EPS: 0.00
ADN.AX income_statement (annual, 2021-06-30) — EBIT: -6327887.00
ADN.AX income_statement (annual, 2021-06-30) — EBITDA: -6234660.00
ADN.AX income_statement (annual, 2021-06-30) — Earnings From Equity Interest: -262583.00
ADN.AX balance_sheet (annual, 2021-06-30) — Employee Benefits: 30679.00
ADN.AX cash_flow (annual, 2021-06-30) — End Cash Position: 4904719.00
ADN.AX cash_flow (annual, 2021-06-30) — Financing Cash Flow: 7923679.00
ADN.AX cash_flow (annual, 2021-06-30) — Free Cash Flow: -6860315.00
ADN.AX balance_sheet (annual, 2021-06-30) — Gains Losses Not Affecting Retained Earnings: 5838594.00
ADN.AX income_statement (annual, 2021-06-30) — General And Administrative Expense: 5090390.00
ADN.AX balance_sheet (annual, 2021-06-30) — Gross PPE: 13679466.00
ADN.AX income_statement (annual, 2021-06-30) — Interest Income: 8636.00
ADN.AX income_statement (annual, 2021-06-30) — Interest Income Non Operating: 8636.00
ADN.AX cash_flow (annual, 2021-06-30) — Interest Received Cfi: 9072.00
ADN.AX balance_sheet (annual, 2021-06-30) — Invested Capital: 16489210.00
ADN.AX cash_flow (annual, 2021-06-30) — Investing Cash Flow: -4280046.00
ADN.AX balance_sheet (annual, 2021-06-30) — Investments And Advances: 467138.00
ADN.AX balance_sheet (annual, 2021-06-30) — Investmentsin Associatesat Cost: 282638.00
ADN.AX cash_flow (annual, 2021-06-30) — Issuance Of Capital Stock: 8021735.00
ADN.AX balance_sheet (annual, 2021-06-30) — Long Term Capital Lease Obligation: 26591.00
ADN.AX balance_sheet (annual, 2021-06-30) — Long Term Debt And Capital Lease Obligation: 26591.00
ADN.AX balance_sheet (annual, 2021-06-30) — Long Term Equity Investment: 282638.00
ADN.AX balance_sheet (annual, 2021-06-30) — Machinery Furniture Equipment: 212960.00
ADN.AX cash_flow (annual, 2021-06-30) — Net Common Stock Issuance: 7996679.00
ADN.AX income_statement (annual, 2021-06-30) — Net Income: -6443299.00
ADN.AX income_statement (annual, 2021-06-30) — Net Income Common Stockholders: -6443299.00
ADN.AX income_statement (annual, 2021-06-30) — Net Income Continuous Operations: -6443299.00
ADN.AX income_statement (annual, 2021-06-30) — Net Income From Continuing And Discontinued Operation: -6443299.00
ADN.AX income_statement (annual, 2021-06-30) — Net Income From Continuing Operation Net Minority Interest: -6443299.00
ADN.AX income_statement (annual, 2021-06-30) — Net Income Including Noncontrolling Interests: -6443299.00
ADN.AX income_statement (annual, 2021-06-30) — Net Interest Income: 8636.00
ADN.AX cash_flow (annual, 2021-06-30) — Net Investment Purchase And Sale: -400006.00
ADN.AX income_statement (annual, 2021-06-30) — Net Non Operating Interest Income Expense: 8636.00
ADN.AX cash_flow (annual, 2021-06-30) — Net Other Financing Charges: -146000.00
ADN.AX cash_flow (annual, 2021-06-30) — Net Other Investing Changes: 1233663.00
ADN.AX balance_sheet (annual, 2021-06-30) — Net PPE: 13350349.00
ADN.AX cash_flow (annual, 2021-06-30) — Net PPE Purchase And Sale: -112613.00
ADN.AX balance_sheet (annual, 2021-06-30) — Net Tangible Assets: 16489210.00
ADN.AX balance_sheet (annual, 2021-06-30) — Non Current Deferred Liabilities: 1863643.00
ADN.AX balance_sheet (annual, 2021-06-30) — Non Current Deferred Revenue: 1863643.00
ADN.AX balance_sheet (annual, 2021-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 30679.00
ADN.AX income_statement (annual, 2021-06-30) — Normalized EBITDA: -6234660.00
ADN.AX income_statement (annual, 2021-06-30) — Normalized Income: -6443299.00
ADN.AX income_statement (annual, 2021-06-30) — Operating Income: -6327887.00
ADN.AX balance_sheet (annual, 2021-06-30) — Ordinary Shares Number: 2158620327.00
ADN.AX cash_flow (annual, 2021-06-30) — Other Cash Receiptsfrom Operating Activities: 62000.00
ADN.AX balance_sheet (annual, 2021-06-30) — Other Equity Adjustments: 5838594.00
ADN.AX income_statement (annual, 2021-06-30) — Other Gand A: 939167.00
ADN.AX income_statement (annual, 2021-06-30) — Other Income Expense: -209758.00
ADN.AX balance_sheet (annual, 2021-06-30) — Other Investments: 184500.00
ADN.AX income_statement (annual, 2021-06-30) — Other Non Operating Income Expenses: 52825.00
ADN.AX income_statement (annual, 2021-06-30) — Other Operating Expenses: 1020191.00
ADN.AX balance_sheet (annual, 2021-06-30) — Other Properties: 13428218.00
ADN.AX balance_sheet (annual, 2021-06-30) — Other Receivables: 853927.00
ADN.AX balance_sheet (annual, 2021-06-30) — Payables: 1110176.00
ADN.AX balance_sheet (annual, 2021-06-30) — Payables And Accrued Expenses: 1110176.00
ADN.AX cash_flow (annual, 2021-06-30) — Paymentsto Suppliersfor Goodsand Services: -1799540.00
ADN.AX balance_sheet (annual, 2021-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 41933.00
ADN.AX income_statement (annual, 2021-06-30) — Pretax Income: -6435782.00
ADN.AX cash_flow (annual, 2021-06-30) — Purchase Of Investment: -400006.00
ADN.AX cash_flow (annual, 2021-06-30) — Purchase Of PPE: -112613.00
ADN.AX balance_sheet (annual, 2021-06-30) — Receivables: 853927.00
ADN.AX income_statement (annual, 2021-06-30) — Reconciled Depreciation: 93227.00
ADN.AX income_statement (annual, 2021-06-30) — Rent And Landing Fees: 21276.00
ADN.AX cash_flow (annual, 2021-06-30) — Repurchase Of Capital Stock: -25056.00
ADN.AX balance_sheet (annual, 2021-06-30) — Retained Earnings: -46278906.00
ADN.AX income_statement (annual, 2021-06-30) — Salaries And Wages: 4129947.00
ADN.AX income_statement (annual, 2021-06-30) — Selling And Marketing Expense: 124079.00
ADN.AX income_statement (annual, 2021-06-30) — Selling General And Administration: 5214469.00
ADN.AX balance_sheet (annual, 2021-06-30) — Share Issued: 2158620327.00
ADN.AX balance_sheet (annual, 2021-06-30) — Stockholders Equity: 16489210.00
ADN.AX balance_sheet (annual, 2021-06-30) — Tangible Book Value: 16489210.00
ADN.AX income_statement (annual, 2021-06-30) — Tax Effect Of Unusual Items: 0.00
ADN.AX income_statement (annual, 2021-06-30) — Tax Provision: 7517.00
ADN.AX income_statement (annual, 2021-06-30) — Tax Rate For Calcs: 0.30
ADN.AX balance_sheet (annual, 2021-06-30) — Total Assets: 19576133.00
ADN.AX balance_sheet (annual, 2021-06-30) — Total Capitalization: 16489210.00
ADN.AX balance_sheet (annual, 2021-06-30) — Total Debt: 83565.00
ADN.AX balance_sheet (annual, 2021-06-30) — Total Equity Gross Minority Interest: 16489210.00
ADN.AX balance_sheet (annual, 2021-06-30) — Total Liabilities Net Minority Interest: 3129996.00
ADN.AX balance_sheet (annual, 2021-06-30) — Total Non Current Assets: 13817487.00
ADN.AX balance_sheet (annual, 2021-06-30) — Total Non Current Liabilities Net Minority Interest: 1920913.00
ADN.AX balance_sheet (annual, 2021-06-30) — Working Capital: 4549563.00
ADN.AX income_statement (annual, 2022-06-30) — +Operating Expense: 9137119.00
ADN.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 1966169.00
ADN.AX balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -223279.00
ADN.AX balance_sheet (annual, 2022-06-30) — Assets Held For Sale Current: 250000.00
ADN.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 2661699070.00
ADN.AX income_statement (annual, 2022-06-30) — Basic EPS: 0.00
ADN.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 4904719.00
ADN.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -5106974.00
ADN.AX cash_flow (annual, 2022-06-30) — Capital Expenditure Reported: -4035983.00
ADN.AX balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 846137.00
ADN.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 219250120.00
ADN.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 32853203.00
ADN.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 32853203.00
ADN.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 32853203.00
ADN.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 42918096.00
ADN.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -9828651.00
ADN.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: -5140961.00
ADN.AX cash_flow (annual, 2022-06-30) — Changes In Cash: 27948484.00
ADN.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -5140961.00
ADN.AX balance_sheet (annual, 2022-06-30) — Common Stock: 219250120.00
ADN.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 171190847.00
ADN.AX cash_flow (annual, 2022-06-30) — Common Stock Issuance: 45331913.00
ADN.AX cash_flow (annual, 2022-06-30) — Common Stock Payments: -2303816.00
ADN.AX balance_sheet (annual, 2022-06-30) — Construction In Progress: 92172.00
ADN.AX balance_sheet (annual, 2022-06-30) — Current Assets: 34350414.00